A female cancer profile test, also known as a cancer detection profile, is a series of blood tests that measure tumor markers, which are substances that can be elevated in the blood of some people with certain types of cancers, particularly those affecting females.
Here’s a breakdown of what to expect:
Purpose:
Early detection and monitoring:
These tests can help identify potential cancers early on and monitor the effectiveness of treatment or check for recurrence.
Specific to female cancers:
The tests are designed to detect and monitor cancers that are more common in women, such as breast, ovarian, and cervical cancer.
Common Tests Included:
CA-125:
Measures the level of a protein that can be elevated in the blood of some patients with certain types of cancers, most commonly ovarian cancer.
CA 15.3:
A blood test used as a tumor marker, specifically for breast cancer.
CEA (Carcinoembryonic Antigen):
Measures the amount of CEA in the blood, a protein that may be higher in certain types of cancer, especially colorectal cancer.
Alpha-Fetoprotein (AFP):
Helps to measure levels of Alpha feto protein, which is secreted in the liver. Abnormally high levels can warn against liver cirrhosis, hepatitis or cancers too.
Beta-hCG:
Detects levels of Beta-hCG, which is created during pregnancy. However, elevated levels may also indicate ovarian tumors.
CA 19.9:
Measures CA 19.9, which an antibody released in cases of certain cancer, especially pancreatic cancer.
Important Considerations:
Not a definitive diagnosis:
These tests are not a definitive diagnosis, and further tests may be needed to confirm a cancer diagnosis.
Consult with a doctor:
It’s important to discuss the results of these tests with a doctor to determine the next steps.
Screening vs. Diagnostic:
Some of these tests are used for screening (to detect cancer early), while others are used for diagnosis or monitoring treatment.
Other tests:
In addition to blood tests, other screening tests, such as mammograms, Pap tests, and colonoscopies, are also important for detecting cancer in women.
Individualized approach:
The specific tests and screening recommendations may vary depending on a woman’s age, risk factors, and medical history.
₹5,000.00Original price was: ₹5,000.00.₹3,999.00Current price is: ₹3,999.00.
